eISSN: 2299-0046
ISSN: 1642-395X
Advances in Dermatology and Allergology/Postępy Dermatologii i Alergologii
Current issue Archive Manuscripts accepted About the journal Editorial board Reviewers Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
Search
Editorial Policies
Sarajevo Declaration on Integrity and Visibility of Scholarly Publications
Share:
Send email
Share:
Original paper

Sensitivity of serum galactomannan antigen in the diagnosis of invasive aspergillosis in patients with obstructive pulmonary diseases (asthma and chronic obstructive pulmonary diseases)

Xiaoyan Hu
1
,
Xiaoling Hu
2
,
Yangdan Zhu
1
,
Huijia Hu
1
,
Zhuoping Wang
1

  1. Department of Respiratory, Hangzhou Ninth People’s Hospital, Hangzhou, Zhejiang Province, China
  2. Department of Neurosurgery, Hangzhou Ninth People’s Hospital, Hangzhou, Zhejiang Province, China
Adv Dermatol Allergol
DOI: https://doi.org/10.5114/ada.2024.145208
Online publish date: 2024/11/21
Article file
- Sensitivity.pdf  [0.16 MB]
Get citation
 
 
1. Christenson SA, Smith BM, Bafadhel M, Putcha N. Chronic obstructive pulmonary disease. Lancet 2022; 399: 2227-42.
2. Ritchie AI, Wedzicha JA. Definition, causes, pathogenesis, and consequences of chronic obstructive pulmonary disease exacerbations. Clin Chest Med 2020; 41: 421-38.
3. Ferrera MC, Labaki WW, Han MK. Advances in chronic obstructive pulmonary disease. Annu Rev Med 2021; 72: 119-34.
4. Otu A, Kosmidis C, Mathioudakis AG, et al. The clinical spectrum of aspergillosis in chronic obstructive pulmonary disease. Infection 2023; 51: 813-29.
5. Gaffney S, Kelly DM, Rameli PM, et al. Invasive pulmonary aspergillosis in the intensive care unit: current challenges and best practices. APMIS 2023; 131: 654-67.
6. Trápaga MR, Poester VR, Sanchotene KO, et al. Anti-Aspergillus fumigatus IgG in patients with bronchiectasis and its relationship with clinical outcome. Arch Microbiol 2022; 204: 728.
7. Sheng L, Jiang W, Yao Y, et al. Value evaluation of quantitative aspergillus fumigatus-specific IgG antibody test in the diagnosis of non-neutropenic invasive pulmonary aspergillosis. Inf Drug Resist 2024; 17: 2043-52.
8. Sehgal IS, Dhooria S, Soundappan K, et al. Comparison of three sample types for performing LDBio Aspergillus immunochromatographic technology lateral flow assay for IgG/IgM antibody detection in chronic aspergillosis. Clin Microbiol Infect 2023; 29: 404-5.
9. De Oliveira VF, Silva GD, Taborda M, et al. Systematic review and meta-analysis of galactomannan antigen testing in serum and bronchoalveolar lavage for the diagnosis of chronic pulmonary aspergillosis: defining a cutoff. Eur J Clin Microbiol Infect Dis 2023; 42: 1047-54.
10. Guo L, Wu XL, Wu XL. Aspergillus infection in chronic obstructive pulmonary diseases. Clin Respir J 2023; 17: 129-38.
11. Zhang X, Shang X, Zhang Y, et al. Diagnostic accuracy of galactomannan and lateral flow assay in invasive aspergillosis: a diagnostic meta-analysis. Heliyon 2024; 10: e34569.
12. Jat KR, Chithambaram NS, Kaur J, et al. Prevalence of allergic bronchopulmonary aspergillosis and Aspergillus sensitization in asthmatic children: a systematic review and meta-analysis. J Ped Pulmonol 2023; 2 (Suppl 1): S7-29.
13. Niu S, Liu D, Yang Y, Zhao L. Clinical utility of metagenomic next-generation sequencing in the diagnosis of invasive pulmonary aspergillosis in acute exacerbation of chronic obstructive pulmonary disease patients in the intensive care unit. Front Cel Infect Microbiol 2024; 14: 1397733.
14. Khan S, Bilal H, Shafiq M, et al. Distribution of Aspergillus species and risk factors for aspergillosis in mainland China: a systematic review. Therap Advanc Infect Dis 2024; 11: 20499361241252537.
15. Li W, Chen G, Lin FY, et al. A score for predicting invasive pulmonary aspergillosis in immunocompetent critically ill patients. Eur J Clin Invest 2023; 53: e13985.
16. Gu Y, Ye XP, Liu YX, et al. A risk-predictive model for invasive pulmonary aspergillosis in patients with acute exacerbation of chronic obstructive pulmonary disease. Respir Res 2021; 22: 176.
17. Palanivel J, Mohapatra MM, Rajaram M, et al. Prevalence and risk factors for chronic pulmonary aspergillosis in chronic obstructive pulmonary disease patients with acute exacerbations. Monaldi Arch Chest Dis 2024. doi: 10.4081/monaldi.2024.2927.
18. Molinos-Castro S, Pesqueira-Fontán PM, Rodríguez-Fernández S, et al. Clinical factors associated with pulmonary aspergillosis in patients with chronic obstructive pulmonary disease. Enferm Infecc Microbiol Clin 2020; 38: 4-10.
19. Tirelli C, Amici MDE, Piloni D. Serum Aspergillus-specific IgE, IgG and IgG4 immunoglobulins assessment in the work-up of invasive pulmonary aspergillosis: a prospective cohort study. Minerva Med 2023; 114: 433-43.
Copyright: © 2024 Termedia Sp. z o. o. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (http://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
FEATURED PRODUCTS
BOOKS
• Atopowe Zapalenie Skóry • Choroby alergiczne w praktyce lekarza rodzinnego • Alergologia – kompendium
Termedia
About us Contact
Copyright notice Privacy policy Advertising policy Contact us
Quick links
Journals Books eBooks Events
© 2024 Termedia Sp. z o.o.
Developed by Bentus.